National Association for Female Executives
(NAFE) today named
(NYSE: AZN) one of the top 50 companies for female executives for the fifth consecutive year. AstraZeneca ranks second on this year’s list.
NAFE recognizes organizations for policies and practices that encourage women’s advancement, and in particular, the number of women holding executive positions in the business.
Within AstraZeneca, women lead key teams and functions, including the executive vice president, human resources and corporate affairs; vice president, global compliance strategy and assurance; vice president, human resources, US; vice president, sales and marketing, Cornerstone brands; and vice president, sales and marketing, Growth brands. All US-based women representing US or global functions were considered in the total submission on behalf of AstraZeneca.
“Our goal is to continue to strengthen and diversify our workforce, including women, to ultimately reach their career goals and aspirations,” said Deb Kauffman, Vice President, Human Resources, US. “This recognition showcases AstraZeneca’s ongoing commitment to ensuring we have the talent required to drive a successful business.”
AstraZeneca offers programs that contribute to a supportive working culture for women, including:
- Career development and mentoring programs, including support for women’s advancement
- Diverse employee network groups, including the “AZ Network of Women”
- Work/life resource and employee assistance programs providing confidential, personal support, resources and referrals to help solve a wide range of personal and work-related challenges
The National Association for Female Executives (NAFE), founded in 1972, serves 20,000 members nationwide with networking, tools and solutions to strengthen and grow their careers and businesses.
magazine publishes the annual NAFE Top 50 list.
provides up-to-date information, community for women in business and access to member benefits. NAFE is a division of Working Mother Media, owned by the Bonnier Corporation.
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.